These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 37137346)

  • 1. Community detection in Epstein-Barr virus associated carcinomas and role of tyrosine kinase in etiological mechanisms for oncogenesis.
    Chatterjee S; Sanjeev BS
    Microb Pathog; 2023 Jul; 180():106115. PubMed ID: 37137346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for Epstein Barr virus-associated cancers: a systematic review, critical appraisal, and mapping of the epidemiological evidence.
    Bakkalci D; Jia Y; Winter JR; Lewis JE; Taylor GS; Stagg HR
    J Glob Health; 2020 Jun; 10(1):010405. PubMed ID: 32257153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epstein-Barr virus infection and its role in the expanding spectrum of human diseases.
    Okano M
    Acta Paediatr; 1998 Jan; 87(1):11-8. PubMed ID: 9510440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between PPP1R15A gene polymorphism (rs611251) and Epstein-Barr virus-associated tumors.
    Song Y; Liu S; Zhao Z; Zhang Y; Yang Y; Luo B
    Acta Virol; 2017; 61(4):445-452. PubMed ID: 29186961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating the global burden of Epstein-Barr virus-related cancers.
    Wong Y; Meehan MT; Burrows SR; Doolan DL; Miles JJ
    J Cancer Res Clin Oncol; 2022 Jan; 148(1):31-46. PubMed ID: 34705104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus-associated lymphoproliferative disorders.
    Grywalska E; Markowicz J; Grabarczyk P; Pasiarski M; Roliński J
    Postepy Hig Med Dosw (Online); 2013 May; 67():481-90. PubMed ID: 23752600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus encoded miR-BART11 promotes inflammation-induced carcinogenesis by targeting FOXP1.
    Song Y; Li X; Zeng Z; Li Q; Gong Z; Liao Q; Li X; Chen P; Xiang B; Zhang W; Xiong F; Zhou Y; Zhou M; Ma J; Li Y; Chen X; Li G; Xiong W
    Oncotarget; 2016 Jun; 7(24):36783-36799. PubMed ID: 27167345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetics of Epstein-Barr virus infection.
    Hiraki A; Fujii N; Masuda K; Ikeda K; Tanimoto M
    Biomed Pharmacother; 2001 Sep; 55(7):369-72. PubMed ID: 11669499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequence Variation of Epstein-Barr Virus: Viral Types, Geography, Codon Usage, and Diseases.
    Correia S; Bridges R; Wegner F; Venturini C; Palser A; Middeldorp JM; Cohen JI; Lorenzetti MA; Bassano I; White RE; Kellam P; Breuer J; Farrell PJ
    J Virol; 2018 Nov; 92(22):. PubMed ID: 30111570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epstein-Barr virus--associated diseases in humans.
    Kawa K
    Int J Hematol; 2000 Feb; 71(2):108-17. PubMed ID: 10745621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haematological associations of Epstein-Barr virus infection.
    Okano M
    Baillieres Best Pract Res Clin Haematol; 2000 Jun; 13(2):199-214. PubMed ID: 10942621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epstein-Barr virus and carcinogenesis: beyond Burkitt's lymphoma.
    Shah KM; Young LS
    Clin Microbiol Infect; 2009 Nov; 15(11):982-8. PubMed ID: 19874382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-Mediated Inhibition of Apoptosis in the Context of EBV-Associated Diseases: Molecular Mechanisms and Therapeutic Perspectives.
    Wyżewski Z; Mielcarska MB; Gregorczyk-Zboroch KP; Myszka A
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrete alterations in the BZLF1 promoter in tumor and non-tumor-associated Epstein-Barr virus.
    Gutiérrez MI; Ibrahim MM; Dale JK; Greiner TC; Straus SE; Bhatia K
    J Natl Cancer Inst; 2002 Dec; 94(23):1757-63. PubMed ID: 12464647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr Virus Epithelial Cancers-A Comprehensive Understanding to Drive Novel Therapies.
    Han S; Tay JK; Loh CJL; Chu AJM; Yeong JPS; Lim CM; Toh HC
    Front Immunol; 2021; 12():734293. PubMed ID: 34956172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus and oncogenesis: from latent genes to tumours.
    Young LS; Murray PG
    Oncogene; 2003 Aug; 22(33):5108-21. PubMed ID: 12910248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for Epstein-Barr virus-associated cancers in children.
    Straathof KC; Bollard CM; Rooney CM; Heslop HE
    Oncologist; 2003; 8(1):83-98. PubMed ID: 12604735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanisms of Epstein-Barr Virus-Mediated Oncogenesis].
    Iwakiri D
    Gan To Kagaku Ryoho; 2015 Oct; 42(10):1133-6. PubMed ID: 26489540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral oncogenesis: Epstein-Barr virus.
    Gaffey MJ; Weiss LM
    Am J Otolaryngol; 1990; 11(6):375-81. PubMed ID: 2177957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Role of Epstein-Barr Virus in Modulating Key Tumor Suppressor Genes in Associated Malignancies: Epigenetics, Transcriptional, and Post-Translational Modifications.
    Fierti AO; Yakass MB; Okertchiri EA; Adadey SM; Quaye O
    Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.